Who
Joshua R. Disbrow
Chief Executive Officer
Company insider
Files Form 4 as: Chief Executive Officer, Aytu BioPharma; Director, Zynex; Chief Operating Officer, Ampio Pharmaceuticals.
In numbers
- Trades disclosed
- 62
- Buys
- 11
- Sells
- 0
- Bought
- $882K
- Sold
- $0
- Companies
- 3
- Companies where not an officer
- 1
- First trade
- 15 Dec 2012
- Last trade
- 28 Jul 2026
- Last filed
- 30 Jul 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 28 Jul 2026filed 30 Jul 2026 | AYTU Aytu BioPharmaBiotechnology | SEC FORM 4 Code A | —30,000 at $0.00 | filing |
| 28 Jul 2026filed 30 Jul 2026 | AYTU Aytu BioPharmaBiotechnology | SEC FORM 4 Code A | —30,000 at $0.00 | filing |
| 26 Mar 2026filed 27 Mar 2026 | ZynexMedical Devices | SEC FORM 4 Code D | —12,499 at $0.00 | filing |
| 26 Mar 2026filed 27 Mar 2026 | ZynexMedical Devices | SEC FORM 4 Code D | —89,501 at $0.00 | filing |
| 26 Mar 2026filed 27 Mar 2026 | Zynex | SEC FORM 4 Code D | —12,499 at $0.00 | filing |
| 26 Mar 2026filed 27 Mar 2026 | Zynex | SEC FORM 4 Code D | —89,501 at $0.00 | filing |
| 3 Oct 2025filed 7 Oct 2025 | AYTU Aytu BioPharmaBiotechnology | SEC FORM 4 Code A | —31,446 at $0.00 | filing |
| 3 Oct 2025filed 7 Oct 2025 | AYTU Aytu BioPharmaBiotechnology | SEC FORM 4 Code A | —22,500 at $0.00 | filing |
| 9 Jun 2025filed 10 Jun 2025 | AYTU Aytu BioPharmaBiotechnology | SEC FORM 4 Bought | $100K66,666 at $1.50 | filing |
| 15 May 2025filed 16 May 2025 | Zynex | SEC FORM 4 Code A | —10,000 at $0.00 | filing |
| 28 Feb 2025filed 3 Mar 2025 | AYTU Aytu BioPharmaBiotechnology | SEC FORM 4 Bought | $20K15,000 at $1.30 | filing |
| 6 Nov 2024filed 8 Nov 2024 | AYTU Aytu BioPharmaoption or derivative · Biotechnology | SEC FORM 4 Code A | —38,000 at $0.00 | filing |
| 29 Jul 2024filed 30 Jul 2024 | Zynex | SEC FORM 4 Bought | $58K7,000 at $8.32 | filing |
| 16 May 2024filed 17 May 2024 | Zynex | SEC FORM 4 Code A | —10,000 at $0.00 | filing |
| 11 Aug 2023filed 15 Aug 2023 | AYTU Aytu BioPharmaoption or derivative · Biotechnology | SEC FORM 4 Code A | —35,000 at $0.00 | filing |
| 15 Jun 2023filed 16 Jun 2023 | Zynex | SEC FORM 4 Code A | —10,000 at $0.00 | filing |
| 14 Jun 2023filed 15 Jun 2023 | AYTU Aytu BioPharmaBiotechnology | SEC FORM 4 Bought | $26K14,000 at $1.86 | filing |
| 20 Dec 2022filed 23 Dec 2022 | AYTU Aytu BioPharmaBiotechnology | SEC FORM 4 Code D | —80,000 at $0.00 | filing |
| 19 Dec 2022filed 21 Dec 2022 | AYTU Aytu BioPharmaBiotechnology | SEC FORM 4 Bought | $25K112,371 at $0.22 | filing |
| 18 Nov 2022filed 28 Nov 2022 | AYTU Aytu BioPharmaBiotechnology | SEC FORM 4 Bought | $53K222,000 at $0.24 | filing |
News
No headline names them, or the companies they trade most, lately.